NCT05351788 2023-12-14SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.Phase 2 Recruiting110 enrolled